. 2023 Jan 19;43(3):614–682. doi: 10.1002/med.21933
© 2023 The Authors. Medicinal Research Reviews published by Wiley Periodicals LLC.
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Figure 9.
Nuclear factor erythroid 2‐related factor 2 inhibitors